natur
product
play
pivot
role
drug
discoveri
antiinfect
highlight
fact
nearli
twothird
drug
current
avail
market
treatment
infecti
diseas
natur
product
deriv
thereof
commonli
accept
success
natur
product
prolif
sourc
lead
structur
due
metabolom
evolut
macroand
microorgan
result
accumul
antimicrobi
compound
respons
toward
antagonist
environment
condit
histor
current
use
antiinfect
natur
origin
deriv
soildwel
microorgan
fungi
actinomycet
limit
case
terrestri
plant
antimalari
agent
notabl
exampl
includ
antibiot
penicillin
g
fungu
penicillium
notatum
macrolid
erythromycin
actinomycet
saccharopolyspora
erythraea
antimalari
compound
artemisinin
plant
artemisia
annua
agent
introduc
socal
golden
era
antibiot
discoveri
howev
develop
novel
antibiot
dramat
drop
past
sever
decad
partial
base
mislead
notion
battl
microbi
infect
moreov
recent
year
emerg
microbi
drug
resist
mani
clinic
use
antiinfect
drug
jeopard
treatment
efficaci
particular
accord
world
health
organ
resist
strain
gramposit
bacteria
staphylococcu
aureu
enterococcu
sp
gramneg
bacteria
klebsiella
pneumonia
pseudomona
aeruginosa
acinetobact
baumannii
mycobacterium
tuberculosi
candida
sp
plasmodium
falciparum
hiv
among
other
becom
global
threat
antibiot
resist
crisi
may
lead
extrem
sever
public
health
consequ
unless
adequ
global
respons
includ
develop
new
antimicrobi
achiev
thu
discoveri
new
antimicrobi
agent
natur
prefer
new
mechan
action
higher
select
less
sensit
drugresist
develop
remain
import
investig
area
natur
product
research
marinederiv
natur
product
occupi
special
place
deliv
new
drug
pharmaceut
market
rich
sourc
numer
novel
chemic
entiti
pronounc
biolog
activ
exemplifi
fact
last
two
decad
number
fdaemaapprov
marin
drug
ziconotid
ester
eribulin
mesyl
brentuximab
vedotin
trabectedin
substanti
increas
sinc
discoveri
unusu
nucleosid
spongothymidin
spongouridin
spong
tethya
crypta
lead
first
marin
drug
araa
vidarabin
arac
cytarabin
late
fig
literatur
data
shown
major
metabolit
includ
enter
clinic
trial
mainli
develop
area
analgesia
cancer
howev
follow
success
marinederiv
natur
product
drug
discoveri
marin
organ
captur
wide
attent
promis
sourc
antimicrobi
bioprospect
highlight
consider
rise
public
recent
year
deal
discoveri
antiinfect
agent
present
chapter
provid
overview
key
public
marin
antiinfect
compound
variou
marin
sourc
classifi
primarili
accord
spectrum
antimicrobi
activ
antibacteri
antifung
antivir
antiprotozo
compound
subdivis
base
natur
sourc
includ
marin
microorgan
bacteriafungi
macroorgan
alga
invertebr
exampl
new
antimicrobi
compil
focu
structur
featur
structureact
relationship
modeofact
studi
marin
microbi
metabolit
well
known
chemic
divers
structur
broad
biolog
activ
twentyfourmemb
macrolactin
frequent
produc
bacillu
strain
possess
antibacteri
anticanc
antivir
activ
cultur
broth
bacterium
bacillu
sp
isol
marin
sediment
sampl
collect
ieodo
korea
southern
reef
found
produc
three
macrolid
includ
macrolactin
q
w
macrolactin
w
show
antibacteri
activ
gramposit
gramneg
pathogen
bacteria
bacillu
subtili
kctc
staphylococcu
aureu
kctc
escherichia
coli
kctc
pseudomona
aeruginosa
kctc
minimum
inhibitori
concentr
mic
valu
serial
dilut
assay
howev
cytotox
activ
record
differ
cancer
cell
line
emphas
import
select
antibacteri
drug
candid
macrolid
featur
oxetan
ring
epoxid
moieti
tetrahydropyran
ring
configur
assign
calcul
coupl
constant
analysi
roesi
spectra
perform
modifi
mosher
method
compound
exhibit
mic
b
subtili
kctc
e
coli
kctc
saccharomyc
cerevisia
kctc
broth
dilut
assay
presenc
oxygen
mandatori
antibacteri
activ
macrolactin
analogu
obtain
cultur
broth
b
subtili
strain
isol
marin
sediment
sampl
obtain
gageocho
korea
southern
reef
new
compound
gageomacrolactin
known
macrolactin
b
f
w
exhibit
signific
broadspectrum
antibacteri
antifung
activ
compound
reveal
antibacteri
activ
gramposit
aureu
b
subtili
bacillu
cereu
gramneg
e
coli
salmonella
typhi
p
aeruginosa
bacteria
mic
valu
rang
vs
azithromycin
posit
control
mic
isol
compound
inhibit
also
myceli
growth
fungi
aspergillu
niger
cerevisia
candida
acutatum
candida
albican
mic
valu
rang
vs
amphotericin
b
posit
control
mic
structur
activ
relationship
sar
studi
reveal
hydroxyl
function
macrolacton
moieti
essenti
antimicrobi
activ
result
emphas
impact
macrolactin
potenti
antibacterialfungicid
drug
proteobacteria
deriv
marin
environ
prolif
produc
mani
new
bioactiv
metabolit
crude
extract
pseudoalteromona
sp
cmmed
associ
nudibranch
collect
shallow
water
kaneoh
bay
oahu
hawaii
display
signific
broadspectrum
antibiot
activ
aureu
atcc
methicillinresist
staphylococcu
aureu
atcc
e
coli
atcc
chromatograph
workup
afford
compound
show
potent
antimicrobi
activ
methicillinresist
aureu
mrsa
mic
valu
low
rang
pyrrol
exhibit
activ
mrsa
mic
mechan
antimicrobi
activ
compound
suggest
due
abil
disrupt
bacteri
cell
wall
membran
wherea
human
erythrocyt
lyse
compound
appli
dose
pyrrol
mrsacaus
infect
challeng
problem
commun
hospit
set
extract
strain
streptomyc
sp
isol
marin
sediment
sampl
collect
ca
depth
nases
shorelin
viti
levu
fiji
exhibit
potent
antibiot
activ
mrsa
chromatograph
workup
afford
fijimycin
ac
addit
etamycin
antibacteri
activ
metabolit
assess
three
mrsa
strain
hospitalassoci
strain
sequenc
hospitalassoci
strain
sanger
communityassoci
strain
fijimycin
c
etamycin
exhibit
strong
medium
antibiot
activ
three
mrsa
strain
mic
valu
rang
weak
activ
fijimycin
b
indic
unit
essenti
antibacteri
activ
similar
antimicrobi
activ
stereoisom
fijimycin
etamycin
suggest
substitut
dfor
neglig
effect
regard
antimrsa
activ
streptomyc
sp
isol
marin
sediment
sampl
obtain
heishijiao
bay
dalian
peopl
republ
china
pr
china
wu
et
al
select
strain
investig
base
polymeras
chain
reaction
pcr
screen
target
strain
may
produc
glycosyl
antibiot
investig
cultur
broth
studi
streptomyc
sp
afford
two
new
deriv
along
four
known
one
among
purifi
compound
dehydroelaiophylin
elaiophylin
efomycin
g
potent
one
differ
mrsa
strain
vancomycinresist
enterococci
vre
mic
valu
rang
addit
also
activ
methicillinresist
staphylococcu
epidermidi
mrse
mic
rang
crossresist
observ
erythromycin
azithromycin
macrolid
confirm
activ
elaiophylin
lacton
affect
macrolid
resist
mechan
gramposit
bacteria
sar
studi
reveal
hemiket
moieti
posit
import
antibacteri
activ
wherea
substitut
ethyl
group
methyl
group
reduc
activ
therebi
prove
essenti
role
alkyl
group
posit
chemic
investig
marin
bacterium
streptomyc
sp
deriv
sediment
sampl
collect
south
moll
island
queensland
australia
led
isol
firstinclass
glycohexadepsipeptidepolyketid
mollemycin
mollemycin
show
pronounc
activ
panel
gramposit
bacteria
includ
aureu
strain
atcc
atcc
epidermidi
atcc
b
subtili
strain
atcc
atcc
well
gramneg
bacteria
e
coli
atcc
p
aeruginosa
atcc
ic
valu
rang
ngml
moreov
compound
except
potent
drugsensit
multidrugresist
clone
malaria
parasit
p
falciparum
ic
valu
ngml
respect
wherea
exhibit
least
lower
cytotox
toward
human
neonat
foreskin
fibroblast
cell
verifi
compound
potenti
lead
antimalari
agent
investig
bioassayguid
fraction
etoac
extract
streptomyc
sp
isol
sediment
sampl
collect
gaviota
state
beach
california
usa
yield
structur
uniqu
macrolid
term
anthracimycin
compound
exhibit
potent
activ
panel
gramposit
pathogen
includ
bacillu
anthraci
e
faecali
pneumonia
well
methicillinand
vancomycinresist
strain
aureu
mic
valu
less
moreov
show
mark
effect
growth
rate
mrsa
even
submic
concentr
mic
compar
antibacteri
agent
vancomycin
notabl
exhibit
low
mammalian
cell
cytotox
ic
valu
shown
exert
synergist
effect
human
cathelicidin
mrsa
growth
investig
employ
optim
macromolecular
synthesi
assay
indic
disrupt
nucleic
acid
synthesi
concentr
near
mic
thu
suggest
effect
might
relat
mode
action
follow
intrigu
result
murin
periton
model
infect
employ
ascertain
vivo
efficaci
interestingli
anthracimycin
singl
ip
inject
dose
mgkg
even
one
hour
mrsa
infect
provid
suffici
protect
mortal
well
toler
mice
thu
suggest
potenti
novel
lead
scaffold
mrsa
interestingli
compound
first
natur
rifamycin
bear
group
moreov
structur
compound
featur
unpreced
heterocycl
core
connect
ansa
bridg
thu
form
novel
ansa
macrolid
templat
isol
compound
togeth
two
refer
compound
rifamycin
lack
substitu
evalu
antimicrobi
activ
mrsa
e
coli
tuberculosi
among
isol
compound
rifamycin
display
except
antibacteri
activ
mic
valu
rang
ngml
higher
refer
compound
moreov
sporalactam
b
show
select
activ
tuberculosi
broth
macrophag
mic
valu
ngml
respect
compar
data
impli
substitu
well
play
import
role
antimicrobi
potenc
metabolit
probabl
favor
bind
rna
polymeras
azaphilon
produc
sever
fungal
genera
includ
aspergillu
monascu
penicillium
six
unpreced
azaphilon
comazaphilon
af
obtain
extract
penicillium
commun
fungu
deriv
marin
sediment
sampl
obtain
depth
southern
china
sea
comazaphilon
c
shown
activ
mrsa
p
fluorescen
b
subtili
mic
valu
respect
comazaphilon
activ
mrsa
p
fluorescen
mic
valu
respect
comazaphilon
e
activ
p
fluorescen
b
subtili
mic
valu
respect
mic
valu
posit
control
ampicillin
rang
sar
studi
show
posit
doubl
bond
orsellin
acid
moieti
azaphilon
core
structur
affect
antibacteri
activ
respect
compound
infect
pathogen
bacteria
often
due
format
microbi
biofilm
medic
devic
often
contamin
staphylococcu
epidermidi
biofilm
involv
transmiss
infect
scopel
et
al
succeed
isol
dipeptid
ciscyclo
leucyltyrosyl
cultur
broth
penicillium
sp
fungal
strain
obtain
spong
axinella
corrugata
collect
south
brazil
ciscyclo
leucyltyrosyl
select
inhibit
biofilm
format
thu
point
promis
broadspectrum
drug
candid
purpos
identifi
novel
antibiot
microbi
sourc
seri
isol
fungu
aspergillu
sp
obtain
marin
cultur
collect
china
among
asperpyronetyp
metabolit
fonsecinon
c
form
via
linkag
display
signific
antibacteri
activ
toward
extend
spectrum
betalactamas
esbl
produc
e
coli
mic
follow
dimer
aurasperon
e
linkag
mic
equipot
inhibitori
effect
posit
control
amikacin
ceftriaxon
respect
subsequ
molecular
dockingbas
target
identif
studi
employ
reveal
bacteri
enoylacyl
carrier
protein
reductas
fabi
key
enzym
bacteri
fatti
acid
synthesi
possibl
antibacteri
target
compound
confirm
result
compound
subject
fabi
inhibit
assay
shown
inhibit
fabi
concentrationdepend
manner
thu
indic
effect
like
relat
mode
action
metabolit
diketopiperazin
dkp
widespread
natur
show
divers
biolog
activ
disrupt
biofilm
format
aspergillu
versicolor
isol
bohai
sea
sediment
pr
china
ferment
strain
yield
brevianamid
rare
natur
dimer
dkp
antitubercular
activ
three
monomer
dkp
brevianamid
u
v
along
known
brevianamid
n
k
deoxybrevianamid
e
among
isol
metabolit
exhibit
antibacteri
activ
bacil
bcg
mic
valu
versu
posit
control
isoniazid
mic
spite
moder
effect
select
toward
bcg
make
brevianamid
potenti
new
drug
candid
nextgener
antibiot
treatment
mycobacterium
tuberculosi
fungu
nigrospora
sp
isol
fresh
tissu
unidentifi
sea
anemon
collect
weizhou
coral
reef
south
china
sea
pr
china
afford
two
new
hydroanthraquinon
deriv
togeth
seven
known
anthraquinon
nigrosporin
b
bostrycin
austrocortirubin
well
ten
acetyl
deriv
isol
compound
evalu
antibacteri
activ
differ
bacteri
strain
structur
unpreced
alkaloid
curvulamin
report
fungu
curvularia
sp
isol
fish
pennahia
argentata
isotopefeed
enzym
inhibit
studi
suggest
uniqu
carbon
framework
deriv
two
unpreced
oligoketid
extend
unit
form
via
decarboxyl
condens
tetraketid
acylcoa
substrat
amino
acid
alanin
notabl
curvulamin
exhibit
potent
antibacteri
activ
toward
panel
patientderiv
pathogen
includ
veillonella
parvula
streptococcu
sp
peptostreptococcu
sp
bacteroid
vulgatu
mic
valu
activ
antimicrobi
agent
tinidazol
use
posit
control
mic
likewis
show
activ
vancomycinresist
enterococcu
faecali
enterococcu
faecium
mic
addit
spiromastixon
g
j
k
l
show
pronounc
antibacteri
effect
gramposit
strain
aureu
bacillu
thuringiensi
b
subtili
mic
valu
less
compar
posit
control
penicillin
g
howev
compound
found
inact
gramneg
bacterium
e
coli
mic
suggest
select
antibacteri
action
moreov
comparison
antibacteri
properti
isol
spiromastixon
reveal
increas
chlorin
substitut
well
omethyl
ring
c
essenti
structur
featur
antibacteri
activ
compound
thu
pronounc
growth
inhibit
effect
toward
sever
gramposit
bacteria
includ
drugresist
clinic
isol
render
metabolit
attract
antibiot
develop
green
alga
prolif
sourc
bioactiv
constitu
promin
member
group
ulva
fasciata
delil
famili
ulvacea
commonli
known
sea
lettuc
grow
coastal
region
asiapacif
numer
compound
terpen
polyphenol
compound
steroid
report
u
fasciata
compound
includ
two
potent
antibacteri
agent
compound
activ
vibrio
parahaemolyticu
vibrio
harveyi
mic
sar
studi
reveal
electroneg
hydroxyl
carbonyl
group
essenti
proton
exchang
reaction
basic
amino
acyl
residu
activ
site
virul
enzym
pathogen
bacteria
brown
alga
commonli
found
tropic
subtrop
water
especi
atlant
pacif
indian
ocean
caribbean
mediterranean
sea
sea
japan
secondari
metabolit
frequent
isol
brown
alga
sesquiterpen
diterpen
shown
exhibit
antibacteri
antivir
cytotox
algicid
antifoul
antifeed
andor
ichthyotox
activ
chromatograph
separ
ch
cl
meoh
extract
brown
alga
dilophu
spirali
collect
elafoniso
island
greec
yield
seventeen
diterpen
featur
dolabellan
skeleton
compound
show
weak
moder
activ
six
strain
aureu
includ
standard
laboratori
strain
atcc
two
epidem
mrsa
strain
macrolideresist
variant
two
multidrugresist
efflux
strain
reduct
devoid
antibacteri
activ
use
nabh
yield
epimer
alcohol
interestingli
semisynthet
compound
show
antibacteri
activ
test
strain
aureu
mic
valu
rang
hydroxyl
group
crucial
antibacteri
activ
wherea
presenc
keton
function
found
natur
product
render
compound
inact
haliclona
spong
wellknown
sourc
polyacetylen
lipid
haliclona
fulva
mediterranean
spong
collect
gulf
napl
itali
chromatograph
workup
butanol
extract
reveal
nine
highli
oxygen
acetylen
fulvyn
ai
whose
structur
includ
long
linear
alkyl
chain
rare
propargyl
acid
termin
moieti
polyoxygen
carbon
isol
compound
exhibit
potent
antibacteri
activ
chloramphenicolresist
strain
b
subtili
mic
rang
three
new
bromotyrosin
analogu
ianthelliformisamin
ac
along
known
aplysamin
araplysillin
isol
spong
suberea
ianthelliformi
collect
north
stradbrok
island
australia
ianthelliformisamin
c
exhibit
antibacteri
activ
gramneg
bacterium
p
aeruginosa
mic
respect
show
activ
aureu
mic
spermin
nucleu
essenti
antibiot
activ
p
aeruginosa
result
suggest
substitut
play
import
role
mediat
antimicrobi
activ
thu
metabolit
repres
potenti
lead
scaffold
drug
develop
mrsaand
k
pneumoniaeassoci
infect
difficult
treat
current
avail
antibiot
uniqu
class
prolinerich
peptid
callyaerin
obtain
indonesian
marin
spong
callyspongia
aerizusa
callyaerin
featur
unusu
core
structur
compris
cyclic
peptid
part
linear
peptid
side
chain
connect
rare
nonproteinogen
z
acid
daa
moieti
among
isol
compound
callyaerin
exhibit
strongest
activ
tuberculosi
mic
ml
addit
found
inact
human
acut
monocyt
leukemia
human
fetal
lung
fibroblast
cell
ic
highlight
potenti
promis
antitubercular
lead
compound
marin
tunic
prolif
sourc
biolog
activ
secondari
metabolit
peptid
alkaloid
anticanc
antivir
antifung
antibacteri
activ
lyophil
specimen
coloni
tunic
pseudodistoma
antinboja
collect
depth
shore
tongyeong
citi
south
sea
korea
extract
meoh
ch
cl
yield
nine
butenolid
cadiolid
cg
display
antibacteri
activ
panel
gramposit
strain
includ
methicillinsensit
aureu
mssa
methicillinresist
aureu
mrsa
strain
mic
rang
among
test
compound
cadiolid
c
potent
one
show
equal
even
stronger
activ
compar
wellknown
antibiot
drug
vancomycin
mic
locat
bromin
atom
found
import
antibiot
activ
investig
compound
free
phenol
group
enhanc
activ
wherea
methyl
reduc
activ
shown
less
activ
permethyl
result
complet
loss
activ
coloni
ascidian
synoicum
sp
promin
sourc
numer
secondari
metabolit
show
varieti
biolog
activ
exampl
includ
cytotox
palmerolid
ecdysteroid
tetrahydrocannabinol
deriv
prunolid
ac
number
rubrolid
antidiabet
tiruchanduramin
antiinflammatori
halogen
furanon
ezrubrolid
pulmonaria
abund
arcticbor
water
north
sea
deep
cold
water
west
scotland
northern
ireland
subarct
ascidian
pulmonaria
obtain
norwegian
coast
afford
novel
bromin
guanidinium
oxazolidinon
name
synoxazolidinon
b
ring
present
compound
rare
natur
product
synoxazolidinon
show
promis
antibacteri
activ
gramposit
aureu
well
mrsa
mic
valu
case
moreov
featur
mic
valu
test
gramposit
bacterium
corynebacterium
glutamicum
synoxazolidinon
b
display
lower
activ
mrsa
mic
weaker
activ
compar
corrobor
import
chlorin
substitu
antibacteri
activ
chemic
investig
marinederiv
actinobacterium
actinomadura
sp
obtain
ascidian
ecteinascidia
turbinata
led
isol
novel
polyketid
forazolin
interestingli
exhibit
vivo
efficaci
murin
model
infect
c
albican
concentr
rang
mgkg
compar
amphotericin
b
without
appar
toxic
chemic
genom
approach
yeast
cerevisia
indic
possibl
dysregul
phospholipid
homeostasi
thu
affect
cell
membran
integr
evalu
hypothesi
membran
permeabl
studi
employ
show
caus
permeabil
fungal
membran
dosedepend
manner
corrobor
put
mode
action
moreov
found
exert
synergist
effect
clinic
use
antifung
agent
amphotericin
b
thu
repres
potenti
lead
scaffold
develop
antic
albican
agent
deepseat
candidiasi
fungal
infect
commonli
treat
azol
howev
recent
year
seen
increas
number
report
resist
candida
strain
azol
deriv
call
discoveri
new
antifung
drug
target
azoleresist
c
albican
strain
four
new
alkaloid
featur
moieti
includ
didymellamid
ad
obtain
fungu
stagonosporopsi
cucurbitacearum
isol
unidentifi
spong
collect
atamishi
shizuoka
prefectur
japan
didymellamid
exhibit
broad
antifung
activ
azoleresist
strain
well
azolesensit
c
albican
c
glabrata
cryptococcu
neoforman
mic
valu
respect
didymellamid
b
activ
c
neoforman
mic
valu
spong
genu
melophlu
wellknown
sourc
chemic
divers
bioactiv
secondari
metabolit
tetram
acid
deriv
unpreced
tetram
acid
glycosid
aurantosid
k
isol
melophlu
sp
collect
fiji
island
melanesia
compound
show
pronounc
antifung
activ
amphotericinresist
c
albican
wildtyp
c
albican
mic
valu
respect
aaptaminetyp
alkaloid
heteroaromat
alkaloid
de
naphthyridin
ring
system
show
wide
rang
bioactiv
includ
antimicrobi
antivir
antioxid
cytotox
activ
seven
new
compound
includ
six
new
aaptamin
alkaloid
isol
okinawan
marin
spong
suberit
sp
collect
unten
port
nakijin
okinawa
japan
among
purifi
compound
nakijinamin
display
antifung
activ
c
albican
c
neoforman
mentagrophyt
mic
valu
respect
well
antibacteri
activ
aureu
b
subtili
luteu
mic
valu
respect
nakijinamin
b
f
exhibit
antifung
activ
c
albican
mic
valu
compound
spong
hippospongia
lachn
collect
south
china
sea
pr
china
promis
sourc
antifung
drug
bioassayguid
fraction
etoh
extract
h
lachn
yield
polyketid
hippolachnin
featur
rare
fourmemb
carbon
ring
hippolachnin
exhibit
potent
antifung
activ
pathogen
fungi
c
neoforman
trichophyton
rubrum
microsporum
gypseum
mic
valu
respect
antivir
compound
influenza
type
caus
viru
subtyp
lifethreaten
diseas
lead
million
death
worldwid
drug
avail
treat
viral
infect
gao
oh
z
metabolit
isol
cultur
broth
fungu
penicillium
camemberti
obtain
marin
sediment
mangrov
root
rhizophora
apiculata
collect
hainan
provinc
pr
china
chromatograph
workup
yield
six
new
indolediterpenoid
along
five
known
compound
among
isol
compound
acid
emindol
sb
paspalin
paxillin
reveal
signific
activ
viru
ic
valu
rang
compar
posit
control
ribavirin
potent
compound
least
activ
one
sar
studi
indic
activ
hexacycl
indolediterpenoid
increas
due
presenc
methylen
group
carboxyor
hydroxi
group
posit
hydroxi
group
posit
isopentenyl
group
posit
activ
decreas
phenyl
isoprenyl
pronounc
activ
aliphat
diterpen
moieti
pentacycl
indolediterpen
prove
cyclic
diterpenoid
nucleu
limit
effect
activ
moreov
presenc
togeth
substitu
respons
highest
activ
among
separ
compound
fungu
cladosporium
sp
isol
mangrov
sediment
guangzhou
pr
china
chromatograph
workup
afford
six
new
indol
alkaloid
five
glyantrypin
analogu
six
alkaloid
includ
oxoglyantrypin
norquinadolin
deoxynortryptoquivalin
deoxytryptoquivalin
tryptoquivalin
quinadolin
b
show
antivir
activ
influenza
viru
ic
valu
rang
compar
posit
control
ribavirin
exhibit
ic
valu
potent
antivir
metabolit
balticolid
isol
unidentifi
fungu
collect
coast
greifswald
bodden
baltic
sea
germani
balticolid
display
strong
activ
influenza
viru
herp
simplex
viru
hsv
type
ic
valu
nontox
eukaryot
cell
investig
similar
concentr
bioassayguid
fraction
crude
extract
deepseaderiv
fungu
eurotium
rubrum
isol
sediment
collect
south
atlant
ocean
depth
afford
seri
prenyl
indol
diketopiperazin
alkaloid
antivir
activ
toward
influenza
viru
strain
compound
test
propag
madindurbi
canin
kidney
mdck
cell
known
compound
neoechinulin
b
exhibit
strongest
antivir
activ
ic
valu
moreov
found
exert
high
potenc
oseltamiviror
amantadineand
ribavirinresist
influenza
clinic
isol
ic
valu
rang
respect
howev
show
lack
cytotox
mdck
cell
highlight
select
antivir
activ
subsequ
modeofact
studi
employ
hemagglutin
inhibit
surfac
plasmon
reson
polykaryon
assay
reveal
bind
subunit
hemagglutinin
glycoprotein
block
interact
sialic
acid
receptor
thu
inhibit
attach
viru
host
cell
interestingli
found
inhibit
influenza
viru
strain
propag
without
caus
viral
resist
shown
multipassag
experi
employ
plaqu
format
assay
even
fifth
passag
contrast
clinic
use
antiinfluenza
drug
amantadin
henc
result
demonstr
may
serv
use
lead
compound
develop
new
antiinfluenza
agent
investig
fungu
spiromastix
sp
mccc
see
sect
afford
array
new
aromat
lacton
variou
chlorin
atom
substitu
spiromastilacton
bioactiv
assay
compound
reveal
deriv
bear
pseudodepsidon
skeleton
possess
antivir
activ
spiromastilacton
e
show
strongest
antivir
activ
influenza
viru
propag
mdck
cell
ic
valu
respect
similar
posit
control
oseltamivir
amantadin
find
allow
conclud
monochlorin
ring
b
contrast
dichlorin
import
express
strong
antivir
activ
metabolit
moreov
format
pseudodepsidon
scaffold
essenti
mediat
antivir
properti
sinc
respect
monom
spiromastilacton
unit
divar
acid
unit
b
inact
activ
compound
spiromastilacton
exhibit
broad
antivir
spectrum
toward
influenza
b
virus
includ
oseltamiviror
amantadineresist
clinic
isol
therefor
chosen
modeofact
molecular
dock
studi
accordingli
shown
potenti
bind
hemagglutinin
protein
subunit
adjac
sialic
acid
receptor
bind
pocket
thu
disrupt
hasial
acid
receptor
interact
crucial
attach
influenza
virus
host
cell
moreov
found
inhibit
viral
genom
replic
probabl
via
interf
viral
ribonucleoprotein
complex
verifi
metabolit
potenti
antiinfluenza
lead
structur
develop
paramyxovirida
type
virus
includ
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
among
hmpv
danger
one
caus
signific
morbid
especi
infant
elderli
patient
brown
seawe
stypopodium
zonal
common
along
brazilian
coast
accumul
mainli
meroditerpen
sever
exhibit
antivir
activ
two
meroditerpenoid
atomar
acid
epitaondiol
obtain
zonal
methyl
ester
atomar
acid
prepar
semisynthesi
compound
exhibit
antivir
activ
hmpv
replic
show
select
indic
respect
epitaondiol
exhibit
potent
antihmpv
activ
ic
compar
atomar
acid
methyl
ester
ic
parent
compound
atomar
acid
ic
compound
exert
effect
uniqu
mechan
atomar
acid
interact
viral
particl
outsid
host
cell
thu
prevent
infect
cell
cultur
compound
effect
cellular
receptor
viral
penetr
meroditerpen
epitaondiol
inhibit
penetr
viral
particl
cell
without
affect
postpenetr
stage
interact
cellular
receptor
methyl
ester
atomar
acid
inhibit
penetr
viral
particl
without
exhibit
effect
postpenetr
event
cellular
receptor
compound
show
select
antivir
activ
low
cytotox
activ
cell
thu
highlight
potenti
inhibit
hmpv
vitro
sever
acut
respiratori
syndrom
sar
sever
pneumonia
caus
novel
human
coronaviru
sarscov
sarscov
pro
play
crucial
role
viral
replic
betulin
acid
indigo
alo
emodin
biflavonoid
amentoflavon
quinonemethid
triterpenoid
among
natur
occur
inhibitor
park
et
al
succeed
isol
nine
phlorotannin
ethanol
extract
ecklonia
cava
edibl
brown
alga
six
isol
compound
show
antisarscov
pro
activ
includ
phlorotannin
deriv
eckol
fucodiphloroethol
g
dieckol
phlorofucofuroeckol
ic
valu
dieckol
potent
deriv
encount
ic
valu
compar
posit
control
hesperetin
chromatograph
workup
red
alga
neorhodomela
aculeata
collect
port
nama
south
korea
afford
new
compound
lanosol
along
five
known
polybromocatechol
two
isol
compound
exhibit
antivir
activ
alcohol
lanosol
polybromocatechol
methoxymethyldiphenylmethan
compound
exhibit
antivir
activ
ic
valu
compound
reveal
activ
ic
valu
activ
ic
valu
posit
control
ribavirin
exhibit
ic
respect
compound
cytotox
make
potenti
drug
candid
new
antivir
drug
two
differ
human
rhinovirus
base
cyclic
condens
substitut
pattern
pyrrol
ring
compound
classifi
lamellarin
lukianol
polycitrin
polyciton
storniamid
ningalin
dopaderiv
alkaloid
found
exert
sever
pharmacolog
activ
cytotox
integras
inhibit
multidrug
resist
revers
activ
addit
immunomodulatori
activ
fifteen
new
dopaderiv
pyrrol
alkaloid
baculiferin
ao
isol
marin
spong
iotrochota
baculifera
collect
south
china
sea
pr
china
compound
found
featur
one
three
osulf
unit
among
isol
compound
baculiferin
c
eh
kn
exhibit
potent
inhibitori
activ
iiib
viru
ic
valu
rang
interestingli
compound
show
weak
moder
activ
tumor
cell
line
bind
activ
compound
target
includ
recombin
transmembran
protein
vif
viral
infect
factor
human
innat
intracellular
antivir
factor
evalu
elucid
mechan
antihiv
activ
baculiferin
contain
nacetyl
group
found
show
highest
bind
affin
toward
vif
ru
ru
bind
activ
compound
suggest
antivir
activ
compound
due
interact
target
vif
andor
soft
coral
genu
sinularia
alcyoniida
wellknown
sourc
macrocycl
norcembranoid
mani
macrocycl
norcembranoid
found
exhibit
wide
array
bioactiv
antifung
cytotox
properti
sinularia
gyrosa
collect
along
coast
dongsha
atol
taiwan
shown
yield
sever
metabolit
purif
aceton
extract
soft
coral
gave
rise
seven
new
norcembranoid
gyrosanoid
ag
addit
known
norcembranoid
among
metabolit
compound
found
show
signific
antivir
activ
human
cytomegaloviru
hcmv
ic
valu
antihcmv
compound
obtain
speci
soft
coral
genu
lobophytum
collect
dongsha
atol
taiwan
well
known
produc
larg
varieti
bioactiv
secondari
metabolit
includ
cytotox
antibacteri
antiinflammatori
hivinhibitori
compound
chromatograph
workup
extract
l
durum
gave
rise
five
new
cembranolid
durumolid
mq
durumolid
q
exhibit
signific
antivir
activ
hcmv
ic
valu
malaria
seriou
infecti
diseas
especi
central
south
america
southeast
asia
subsaharan
africa
middl
east
india
caus
plasmodium
parasit
estim
million
peopl
die
everi
year
due
malaria
four
new
alkaloid
includ
marinacarbolin
two
new
indolactam
alkaloid
obtain
cultur
broth
marin
actinomycet
marinactinospora
thermotoleran
scsio
isol
sea
sediment
sampl
northern
south
china
sea
pr
china
obtain
depth
new
compound
exhibit
antiplasmodi
activ
malaria
parasit
p
falciparum
line
ic
valu
rang
intrigu
prodigiosinrel
compound
marineosin
isol
actinomycet
streptomyc
sp
deriv
sediment
collect
shore
la
jolla
california
biosynthet
studi
assist
identifi
correspond
mar
gene
cluster
lead
appear
homolog
similar
red
gene
cluster
describ
soildwel
coelicolor
respons
format
undecylprodigionin
addit
step
requir
spiroamin
function
format
investig
antimalari
potenc
well
two
biosynthet
intermedi
premarineosin
isol
mutant
strain
venezuela
observ
accordingli
ic
valu
p
falciparum
strain
detect
nanomolar
rang
ngml
compar
even
potent
posit
control
chloroquin
notabl
activ
compound
premarineosin
demonstr
high
si
chloroquineresist
p
falciparum
strain
respect
remark
antimalari
activ
fascin
group
secondari
metabolit
inspir
extens
medicin
chemistri
sar
studi
accordingli
kancharla
cowork
screen
librari
bring
function
prodiginin
new
synthes
tambjamin
deriv
natur
occur
tambjamin
found
almost
exclus
marin
invertebr
ie
nudibranch
bryozoan
ascidian
structur
resembl
prodigiosin
bear
enamin
moieti
instead
pyrrol
moieti
ring
c
latter
studi
reveal
bipyrrol
scaffold
tambjamin
improv
bioactiv
profil
regard
vitroin
vivo
antimalari
efficaci
select
particular
analogu
shown
excel
antimalari
lead
activ
multidrugresist
strain
ic
valu
ngml
respect
possess
significantli
lower
cytotox
toward
cell
ic
ngml
si
respect
moreov
subsequ
vivo
studi
exhibit
protect
mice
infect
plasmodium
yoelii
day
administ
oral
day
dose
mgkg
singleadministr
dose
mgkg
wherea
sign
toxic
effect
observ
also
worth
note
propos
synthesi
includ
use
inexpens
access
precursor
cycloheptanamin
involv
challeng
chemic
reaction
thu
tambjamin
prodiginin
proven
privileg
scaffold
librari
design
develop
novel
antimalari
agent
unusu
deriv
isol
salinispora
sp
obtain
marin
sediment
sampl
collect
near
keawekaheka
bay
hawaii
depth
salinipostin
exhibit
potent
activ
chloroquineresist
strain
p
falciparum
ec
valu
ngml
demonstr
remark
select
index
si
furthermor
seri
relat
deriv
salinipostin
bk
isol
chemic
investig
salinispora
sp
allow
explor
structureact
relationship
new
intrigu
class
antimalari
chemic
structur
unambigu
elucid
detail
msm
well
nmr
analysi
includ
p
nmr
absolut
configur
deduc
mean
vcd
evalu
antimalari
activ
share
common
bicycl
phosphotriest
motif
reveal
broad
rang
ec
valu
hint
import
impact
side
chain
r
r
antiparasit
effect
compound
accordingli
deriv
longer
vinyl
andor
branch
r
chain
well
pentadecyl
moieti
r
salinipostin
f
respect
show
significantli
higher
activ
rest
analogu
interestingli
none
compound
display
cytotox
toward
mammalian
cell
indic
high
select
p
falciparum
biolog
studi
p
falciparum
reveal
morpholog
development
chang
parasit
cultur
caus
treatment
potent
compound
salinipostin
differ
appear
result
treatment
chloroquin
suggest
novel
mode
action
moreov
growth
stage
specif
evalu
respect
wash
inwash
experi
indic
earli
stage
parasit
life
cycl
especi
ring
stage
sensit
one
attempt
gener
resist
parasit
popul
toward
fail
thu
suggest
compound
less
suscept
drugresist
develop
current
avail
antimalari
drug
possibl
target
fundament
process
plasmodium
growth
unpreced
polyhydroxyl
macrolid
lacton
ring
bastimolid
isol
recent
describ
tropic
marin
cyanobacterium
okeania
hirsut
collect
caribbean
coast
panama
chemic
convers
respect
nonapnitrobenzo
subsequ
xray
analysi
allow
assign
absolut
configur
bioassay
screen
sever
caus
agent
neglect
parasit
tropic
diseas
reveal
signific
antimalari
activ
nanomolar
concentr
toward
broad
spectrum
drugresist
p
falciparum
strain
respect
ic
valu
ngml
wherea
moder
cytotox
vero
mammalian
cell
observ
ic
two
new
cyclic
depsipeptid
companeramid
b
isol
cyanobacteri
assemblag
collect
coiba
island
panama
interestingli
structur
contain
unusu
amino
acid
acid
amoya
hydroxi
isovaler
acid
hiva
rare
encount
natur
compound
exert
vitro
activ
p
falciparum
strain
low
sub
micromolar
concentr
ic
valu
compound
also
test
cytotox
sever
human
cancer
cell
line
found
nontox
concentr
respect
cytotox
select
compound
higher
concentr
yet
studi
callophycu
serratu
marin
red
alga
found
produc
antimalari
metabolit
found
depth
throughout
tropic
subtrop
pacif
ocean
four
new
bromophycolid
ru
obtain
fijian
red
alga
c
serratu
natur
product
featur
diterpenebenzo
macrolid
core
structur
bromophycolid
show
antimalari
activ
malaria
parasit
p
falciparum
submicromolar
concentr
ic
valu
spong
famili
plakinida
known
accumul
polyketid
featur
cyclic
peroxid
sever
spongederiv
peroxid
show
activ
protozoan
parasit
p
falciparum
leishmania
chagasi
trypanosoma
brucei
brucei
trypanosoma
cruzi
puerto
rican
spong
plakorti
halichondrioid
found
yield
polyketid
endoperoxid
antimalari
assess
p
falciparum
reveal
epiplakinidio
acid
show
potent
activ
mic
valu
semisynthet
deriv
found
show
compar
antimalari
activ
mic
valu
respect
bioassayguid
fraction
australian
marin
spong
plakorti
sp
previous
report
prolif
sourc
antimalari
drug
yield
two
new
cyclic
polyketid
peroxid
q
q
antitrypanosom
assay
show
potent
activ
brucei
brucei
ic
valu
ngml
compound
featur
carboxyl
group
side
chain
show
decreas
activ
compar
plakortid
ru
isol
spong
plakinastrella
mamillari
collect
fiji
island
melanesia
south
pacif
ocean
plakortid
u
potent
compound
encount
exhibit
antiplasmodi
activ
chloroquineresist
p
falciparum
strain
ic
human
african
trypanosomiasi
hat
african
sleep
sick
caus
mainli
two
subspeci
protozoan
parasit
trypanosoma
brucei
rhodesiens
trypanosoma
brucei
gambiens
diseas
treat
usual
fatal
million
peopl
poor
region
africa
endang
diseas
state
caribbean
spong
pandaro
acanthifolium
yield
twelv
steroid
glycosid
includ
pandarosid
ej
along
correspond
methyl
ester
metabolit
featur
unusu
oxid
dring
ci
cd
ring
junction
pandarosid
g
methyl
ester
strongli
inhibit
growth
brucei
rhodesiens
ic
valu
respect
l
donovani
ic
valu
respect
gorgonian
octocor
genu
eunicea
abund
caribbean
sea
consid
rich
sourc
antimalari
compound
numer
natur
product
isol
member
genu
exhibit
uniqu
structur
featur
pronounc
biolog
activ
chromatograph
workup
colombian
gorgonian
coral
genu
eunicea
afford
eighteen
diterpen
dolabellan
type
test
inhibitori
activ
diterpenoid
toward
p
falciparum
chloroquineresist
reveal
compound
activ
ic
valu
rang
particular
dolabellanon
show
pronounc
activ
ic
valu
two
new
alkaloid
name
didemnidin
b
isol
methanol
extract
marin
organ
didemnum
sp
ascidian
obtain
tiwai
wharf
depth
tiwai
point
southland
new
zealand
compound
featur
moieti
connect
posit
spermidin
rare
marin
organ
didemnidin
b
activ
malaria
parasit
p
falciparum
ic
semisynthet
compound
n
n
tertbutoxycarbonylspermidin
show
ic
valu
p
falciparum
brucei
rhodesiens
respect
chemic
investig
marin
ascidian
eudistoma
sp
led
isol
three
unusu
relat
alkaloid
eudistidin
ac
among
eudistidin
c
mixtur
repres
highli
complex
alkaloid
bear
fuse
pyrimidin
imidazol
ring
guanidin
well
amidin
moieti
protondefici
nucleu
eudistidin
c
unambigu
assign
help
new
sensit
nmr
puls
sequenc
lrhsqmbc
longrang
heteronuclear
singlequantum
multiplebond
correl
allow
detect
j
ch
j
ch
correl
total
synthesi
eudistidin
c
confirm
structur
alkaloid
seri
arylsubstitut
deriv
obtain
eudistidin
c
epim
eudistidin
b
synthet
congen
exhibit
signific
antiparasit
activ
chloroquinesensit
chloroquineresist
p
falciparum
strain
ic
valu
rang
antimalari
potenc
compound
investig
employ
plasmodi
lactat
dehydrogenas
activ
assay
artemisinin
chloroquin
posit
control
interestingli
show
stronger
antimalari
activ
toward
p
falciparum
strain
comparison
epim
among
test
compound
synthet
deriv
exhibit
potent
antiplasmodi
effect
strain
mic
valu
respect
moreov
subsequ
cytotox
assay
vero
cell
monkey
kidney
fibroblast
reveal
appar
activ
suggest
select
antimalari
activ
addit
compound
found
inhibit
bind
oncogen
transcript
factor
hypoxiainduc
factor
thu
eudistidin
c
b
b
well
synthet
analogu
carri
tetracycl
eudistidinelik
scaffold
repres
novel
class
lead
structur
develop
potent
select
antimalari
agent
convolutamin
j
obtain
marin
bryozoan
amathia
tortuosa
collect
bass
strait
tasmania
australia
compound
shown
activ
parasit
brucei
brucei
ic
valu
respect
antiinfluenza
continu
natur
product
success
sourc
lead
compound
treatment
infecti
diseas
sinc
dawn
antibiot
era
recent
year
emerg
resist
microbi
strain
virtual
major
class
known
antiinfect
pose
worldwid
health
threat
thu
mine
natur
sourc
novel
antiinfect
agent
emin
marin
macroand
microorgan
systemat
investig
sourc
novel
antiinfect
agent
despit
fact
threequart
earth
surfac
cover
sea
ocean
nevertheless
continu
interest
quest
structur
unpreced
bioactiv
secondari
metabolit
combin
recent
advanc
sampl
techniqu
open
new
avenu
explor
fascin
ecolog
nich
inde
last
decad
increas
marin
bioprospect
effort
observ
particularli
aim
deepsea
environ
provid
novel
lead
matter
fact
potent
proteasom
inhibitor
salinosporamid
marin
sediment
actinomycet
salinispora
tropica
recent
enter
phase
clinic
trial
anticanc
agent
undoubtedli
marin
environ
repres
untap
sourc
bioactiv
chemic
entiti
mani
featur
new
carbon
framework
without
terrestri
counterpart
structur
rich
may
give
rise
potenti
scaffold
explor
new
biolog
target
thu
offer
advantag
discoveri
antiinfect
lead
novel
mechan
action
tackl
global
challeng
pose
antibiot
resist
sever
metabolit
variou
marin
sourc
ie
spong
bacteria
fungi
describ
review
alreadi
identifi
lead
structur
drugsensit
drugresist
pathogen
antivir
spiromastilacton
antibacteri
anthracimycin
antimalari
thiaplakorton
salinipostin
possess
activ
sub
micromolar
concentr
henc
given
enorm
potenti
marin
natur
product
drug
develop
demonstr
success
stori
sever
market
marinederiv
drug
ie
becom
increasingli
appar
ocean
hold
great
promis
next
sourc
novel
antiinfect
agent
